Health Discovery Corporation (HDVY)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -1.74 Million USD | -209.01% |
| 2019 | 1.59 Million USD | 307.64% |
| 2018 | -769.62 Thousand USD | 10.47% |
| 2017 | -859.6 Thousand USD | 9.91% |
| 2016 | -954.14 Thousand USD | -19.17% |
| 2015 | -800.64 Thousand USD | -2182.42% |
| 2014 | 38.44 Thousand USD | 103.07% |
| 2013 | -1.25 Million USD | 31.85% |
| 2012 | -1.83 Million USD | 39.06% |
| 2011 | -3.01 Million USD | 36.97% |
| 2010 | -4.78 Million USD | -138.22% |
| 2009 | -2 Million USD | 8.12% |
| 2008 | -2.18 Million USD | 10.79% |
| 2007 | -2.44 Million USD | 2.93% |
| 2006 | -2.52 Million USD | 18.68% |
| 2005 | -3.1 Million USD | -40.75% |
| 2004 | -2.2 Million USD | -860.43% |
| 2003 | -229.59 Thousand USD | 35.46% |
| 2002 | -355.76 Thousand USD | -2.68% |
| 2001 | -346.47 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 Q3 | -494 Thousand USD | 70.42% |
| 2021 FY | - USD | 100.0% |
| 2021 Q1 | -378 Thousand USD | -6.48% |
| 2021 Q2 | -1.67 Million USD | -341.8% |
| 2020 Q4 | -355 Thousand USD | -22.41% |
| 2020 FY | -1.74 Million USD | -209.01% |
| 2020 Q2 | -773 Thousand USD | -139.78% |
| 2020 Q1 | -322.38 Thousand USD | -127.76% |
| 2020 Q3 | -290 Thousand USD | 62.48% |
| 2019 Q4 | -141.54 Thousand USD | 37.92% |
| 2019 FY | 1.59 Million USD | 307.64% |
| 2019 Q2 | 614 Thousand USD | 467.93% |
| 2019 Q3 | -228 Thousand USD | -137.13% |
| 2019 Q1 | -166.87 Thousand USD | 17.92% |
| 2018 Q3 | -196.51 Thousand USD | -5.8% |
| 2018 FY | -769.62 Thousand USD | 10.47% |
| 2018 Q1 | -184.06 Thousand USD | 0.0% |
| 2018 Q2 | -185.73 Thousand USD | -0.91% |
| 2018 Q4 | -203.3 Thousand USD | -3.46% |
| 2017 FY | -859.6 Thousand USD | 9.91% |
| 2016 FY | -954.14 Thousand USD | -19.17% |
| 2016 Q4 | -187.23 Thousand USD | 15.13% |
| 2016 Q3 | -220.59 Thousand USD | 27.88% |
| 2016 Q2 | -305.86 Thousand USD | -27.2% |
| 2016 Q1 | -240.45 Thousand USD | -34.1% |
| 2015 Q1 | -233.33 Thousand USD | -499.99% |
| 2015 FY | -800.64 Thousand USD | -2182.42% |
| 2015 Q4 | -179.3 Thousand USD | 2.84% |
| 2015 Q3 | -184.55 Thousand USD | 9.29% |
| 2015 Q2 | -203.45 Thousand USD | 12.81% |
| 2014 Q2 | 11.85 Thousand USD | 120.23% |
| 2014 Q3 | 26.83 Thousand USD | 126.46% |
| 2014 FY | 38.44 Thousand USD | 103.07% |
| 2014 Q4 | 58.33 Thousand USD | 117.37% |
| 2014 Q1 | -58.57 Thousand USD | 71.27% |
| 2013 Q4 | -203.89 Thousand USD | -3.28% |
| 2013 Q1 | -415.28 Thousand USD | 39.85% |
| 2013 Q3 | -197.42 Thousand USD | 54.66% |
| 2013 Q2 | -435.46 Thousand USD | -4.86% |
| 2013 FY | -1.25 Million USD | 31.85% |
| 2012 FY | -1.83 Million USD | 39.06% |
| 2012 Q1 | -615.76 Thousand USD | 28.08% |
| 2012 Q3 | 9992.00 USD | 101.85% |
| 2012 Q2 | -541.07 Thousand USD | 12.13% |
| 2012 Q4 | -690.4 Thousand USD | -7009.56% |
| 2011 Q2 | -694.81 Thousand USD | 14.62% |
| 2011 Q4 | -856.13 Thousand USD | -31.65% |
| 2011 Q3 | -650.29 Thousand USD | 6.41% |
| 2011 FY | -3.01 Million USD | 36.97% |
| 2011 Q1 | -813.74 Thousand USD | 57.82% |
| 2010 Q2 | -983.68 Thousand USD | 3.28% |
| 2010 FY | -4.78 Million USD | -138.22% |
| 2010 Q3 | -833.12 Thousand USD | 15.31% |
| 2010 Q4 | -1.92 Million USD | -131.59% |
| 2010 Q1 | -1.01 Million USD | -258.66% |
| 2009 Q4 | -283.56 Thousand USD | 53.82% |
| 2009 Q1 | -558.78 Thousand USD | -17.68% |
| 2009 Q2 | -551.61 Thousand USD | 1.28% |
| 2009 Q3 | -614.02 Thousand USD | -11.31% |
| 2009 FY | -2 Million USD | 8.12% |
| 2008 Q3 | -622.6 Thousand USD | -21.16% |
| 2008 Q1 | -574.18 Thousand USD | -0.11% |
| 2008 FY | -2.18 Million USD | 10.79% |
| 2008 Q4 | -474.82 Thousand USD | 23.74% |
| 2008 Q2 | -513.85 Thousand USD | 10.51% |
| 2007 Q2 | -640.2 Thousand USD | -18.86% |
| 2007 FY | -2.44 Million USD | 2.93% |
| 2007 Q4 | -573.57 Thousand USD | 18.91% |
| 2007 Q3 | -707.31 Thousand USD | -10.48% |
| 2007 Q1 | -538.63 Thousand USD | -3.88% |
| 2006 Q3 | -396.45 Thousand USD | 16.59% |
| 2006 Q4 | -518.54 Thousand USD | -30.79% |
| 2006 FY | -2.52 Million USD | 18.68% |
| 2006 Q1 | -1.13 Million USD | -167.94% |
| 2006 Q2 | -475.29 Thousand USD | 58.07% |
| 2005 Q4 | -423 Thousand USD | 54.2% |
| 2005 FY | -3.1 Million USD | -40.75% |
| 2005 Q1 | -927.92 Thousand USD | 6.26% |
| 2005 Q2 | -829 Thousand USD | 10.66% |
| 2005 Q3 | -923.68 Thousand USD | -11.42% |
| 2004 Q4 | -989.85 Thousand USD | -88.44% |
| 2004 Q3 | -525.29 Thousand USD | -22.99% |
| 2004 Q2 | -427.12 Thousand USD | -58.61% |
| 2004 Q1 | -269.29 Thousand USD | -133.61% |
| 2004 FY | -2.2 Million USD | -860.43% |
| 2003 Q3 | -55.51 Thousand USD | -93.48% |
| 2003 Q4 | -115.27 Thousand USD | -107.63% |
| 2003 Q2 | -28.69 Thousand USD | 5.33% |
| 2003 FY | -229.59 Thousand USD | 35.46% |
| 2003 Q1 | -30.31 Thousand USD | 68.07% |
| 2002 Q2 | -97.04 Thousand USD | -53.95% |
| 2002 Q4 | -94.93 Thousand USD | 5.8% |
| 2002 Q3 | -100.77 Thousand USD | -3.84% |
| 2002 FY | -355.76 Thousand USD | -2.68% |
| 2002 Q1 | -63.03 Thousand USD | 81.12% |
| 2001 FY | -346.47 Thousand USD | 0.0% |
| 2001 Q3 | -5963.00 USD | 0.0% |
| 2001 Q4 | -333.87 Thousand USD | -5499.03% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Achiko AG | -8.35 Million USD | 100.0% |
| Accelera Innovations, Inc | - USD | NaN% |
| Aspyra Inc. | 4.7 Million USD | 100.0% |
| Cannabis Sativa, Inc. | -855.85 Thousand USD | 100.0% |
| CompuMed, Inc. | -31.2 Thousand USD | 100.0% |
| CompuGroup Medical SE & Co. KGaA | 171.25 Million USD | 100.0% |
| Cogstate Limited | 660.18 Thousand USD | 100.0% |
| CareView Communications, Inc. | -688.3 Thousand USD | 100.0% |
| Craneware plc | 19.73 Million USD | 100.0% |
| Caduceus Software Systems Corp. | -1.15 Million USD | 100.0% |
| Certive Solutions Inc. | -2.1 Million USD | 100.0% |
| Drug Free Solution, Inc. | -1.4 Million USD | 100.0% |
| DATATRAK International, Inc. | 1.87 Million USD | 100.0% |
| Strainsforpains, Inc. | -65.61 Thousand USD | 100.0% |
| Healixa Inc. | -6.35 Million USD | 100.0% |
| Easy Technologies Inc. | - USD | NaN% |
| eWellness Healthcare Corporation | - USD | NaN% |
| Founders Bay Holdings | 9.02 Million USD | 100.0% |
| Healthcare Integrated Technologies, Inc. | -983.56 Thousand USD | 100.0% |
| H-Source Holdings Ltd. | - USD | NaN% |
| InterCare DX, Inc. | -789.33 USD | 100.0% |
| IQ-AI Limited | -517.25 Thousand USD | 100.0% |
| Cannabiz Mobile, Inc. | -750.00 USD | 100.0% |
| Mednow Inc. | -17.04 Million USD | 100.0% |
| Galileo Life Sciences, Inc. | -271.37 Thousand USD | 100.0% |
| MediXall Group, Inc. | -6.54 Million USD | 100.0% |
| Mitesco, Inc. | -2.58 Million USD | 100.0% |
| MobileSmith, Inc. | -7.81 Million USD | 100.0% |
| NantHealth, Inc. | -51.32 Million USD | 100.0% |
| Net Medical Xpress Solutions, Inc. | -1.82 Million USD | 100.0% |
| OneLife Technologies Corp. | - USD | NaN% |
| ORHub, Inc. | -12.15 Million USD | 100.0% |
| Patient Access Solutions, Inc. | -9 Million USD | 100.0% |
| Pharma-Bio Serv, Inc. | 1.11 Million USD | 100.0% |
| PPJ Healthcare Enterprises, Inc. | 74.72 Thousand USD | 100.0% |
| Medical Cannabis Payment Solutions, Inc. | -34.1 Thousand USD | 100.0% |
| Renalytix Plc | -29.6 Million USD | 100.0% |
| Revium Recovery Inc. | -679 Thousand USD | 100.0% |
| RYAH Group, Inc. | - USD | NaN% |
| Carepay Inc. | 396.65 Thousand USD | 100.0% |
| Vaso Corporation | 4.19 Million USD | 100.0% |
| Vynleads, Inc. | -235.73 Thousand USD | 100.0% |